Table 1.
Roles of microRNAs in patients with inflammatory bowel disease
What is already known about miRNAs in IBD?
|
What can we expect from miRNAs in IBD?
|
Ref.
|
Regulate cellular processes and homeostasis | Discover new functions in the pathophysiology of IBD | [8-11] |
Differentially expressed between patients with IBD and healthy controls | Can be used as diagnostic markers for IBD | [5,6,16-19] |
Differentially expressed between UC and CD | Can be used to differentiate UC from CD | [6] |
Differentially expressed with respect to disease activity | Can be used as biomarkers of inflammatory activity | [16,17,19,32] |
Regulated in response to drug exposure | Can be used as markers of drug responses | [20] |
Regulate the expression of inflammatory cytokines | Potential therapeutic targets in IBD | [21,22,23] |
Act on the intestinal barrier | Potential therapeutic targets in IBD | [25,26] |
Modulate the intestinal microbiota | Potential therapeutic targets in IBD | [27-29] |
CD: Crohn’s disease; IBD: Inflammatory bowel disease; miRNA: microRNA; UC: Ulcerative colitis.